Content area
Abstract
To the Editor: In their review article, de Cabo and Mattson (Dec. 26 issue)1 suggest potential positive effects of intermittent fasting. We would like to highlight safety concerns regarding intermittent fasting in persons with diabetes mellitus. Furmli et al. reported a considerable reduction in or elimination of the need for oral antihyperglycemic agents and insulin in persons with type 2 diabetes after the onset of fasting.2 In a prospective trial involving adults with type 2 diabetes who were participating in a 5:2 intermittent fasting regimen (fasting 2 days each week), the mean medication effect score for oral antihyperglycemic agents and . . .
Details
1 University of Maryland School of Medicine, Baltimore, MD